Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
Open accessThe DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index.
Abstract
Neurodegeneration elicits neuroinflammatory responses to kill pathogens, clear debris and support tissue repair. Neuroinflammation is a dynamic biological response characterized by the recruitment of innate and adaptive immune system cells in the site of tissue damage. Resident microglia and infiltrating immune cells partake in the restoration of central nervous system homeostasis. Nevertheless, their activation may shift to chronic and aggressive responses, which jeopardize neuron survival and may contribute to the disease process itself. Positron Emission Tomography (PET) molecular imaging represents a unique tool contributing to in vivo investigating of neuroinflammatory processes in patients. In the present review, we first provide an overview on the molecular basis of neuroinflammation in neurodegenerative diseases with emphasis on microglia activation, astrocytosis and the molecular targets for PET imaging. Then, we review the state-of-the-art of in vivo PET imaging for neuroinflammation in dementia conditions associated with different proteinopathies, such as Alzheimer’s disease, frontotemporal lobar degeneration and Parkinsonian spectrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Methods to image microglia exist and are being used to test the effect of treatments on microglia205–210.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“The activation of microglia cells is a specific adapting reaction of the brain’s innate immune system, found in both physiological and pathological conditions [22].”
BackgroundNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 6×
“As for Aβ peptides deposition and neurofibrillary tangles formation, the key AD pathological hallmarks, neuroinflammation is now considered as a third component, which actively contributes to disease progression and chronic degeneration [25].”
BackgroundInfluentialFate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 1×
“Microglia cells are tissue-resident mononuclear phagocytes of myeloid lineage, originating from erytromyeloid progenitors formed in the yolk sac, which makes them different from all the other central nervous system (CNS) macrophages formed in the bone marrow [17,18].”
BackgroundFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 7×
“While surveying, whenever microglia cells detect a noxa disturbing tissue homeostasis, they undergo a stepwise transformation towards an effector functional and morphological phenotype [20].”
BackgroundInfluentialTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“Based on solid preclinical and clinical data showing that immune system-mediated actions actively contribute to and drive AD pathogenesis [72], there was an increasing interest on the role of neuroinflammation within the pathological mechanisms occurring during the course of the disease [25].”
BackgroundMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 2×
“This is especially true for the multiple functional phenotypes that microglia can adopt, which can dynamically switch in accordance with changes in the environment, thus delineating a very complex and dynamic system [9,24,28].”
Background
Cited by
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 366
“The same results have been obtained by positron emission tomographic (PET) analysis in living PD patients [28,29].”
BackgroundMicroglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Werry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
“Whether neuroinflammation is a primary or secondary event and whether it has an overall beneficial or detrimental effect is hotly debated [3,27,28].”
BackgroundNeuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Sălcudean, A., Bodo, C.-R., Popovici, R. A., Lica, M. M., Păcurar, M., Crăciun, R.-E., Crișan, A., ENĂTESCU, V. R., Marinescu, I. P., Cîmpian, D. M., et al. (2025) · Biomolecules · doi:10.3390/biom15040502 · Cited by 201
“However, when activated by various pathological stimuli, including neurodegeneration, microglia can adopt a proinflammatory phenotype, leading to the release of cytokines, chemokines, and other mediators that perpetuate inflammation and contribute to neuronal loss [37,38].”
McCluskey, S. P., Plisson, C., Rabiner, E. A., & Howes, O. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04488-0 · Cited by 120
Tondo, G., Iaccarino, L., Caminiti, S. P., Presotto, L., Santangelo, R., Iannaccone, S., Magnani, G., & Perani, D. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00619-0 · Cited by 107
Self-citationSerum Exosomal miR-223 Serves as a Potential Diagnostic and Prognostic Biomarker for Dementia
Wei, H., Xu, Y., Xu, W., Zhou, Q., Chen, Q., Yang, M., Feng, F., Liu, Y., Zhu, X., Yu, M., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.016 · Cited by 84
TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
Tondo, G., Perani, D., & Comi, C. (2019) · Disease Markers · doi:10.1155/2019/2387614 · Cited by 88
“Increasing data provided by several PET studies, especially in AD, confirm that microglial activation accompanies neurodegeneration, particularly in the early phase, where a therapeutic approach might be beneficial [130].”
Self-citationTherapeutic strategies for glucose transporter 1 deficiency syndrome
Tang, M., Park, S. H., Vivo, D. C. D., & Monani, U. R. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50881 · Cited by 83
“Thus, for instance, the microvasculature could potentially be examined using arterial spin labeling to measure cerebral perfusion, while the extent of neuroinflammation may be gleaned by exploiting PET imaging and ligands such as (11)C-PK11195 and (11)C-deuterium-ldeprenyl which bind the microglial translocator protei…”
BackgroundJorgensen, D. R., Shaaban, C. E., Wiley, C. A., Gianaros, P. J., Mettenburg, J., & Rosano, C. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00535.2017 · Cited by 71
Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials
Kello, N., Anderson, E., & Diamond, B. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40933 · Cited by 77
“Of note, TSPO overexpression in the hippocampus is found in AD and Parkinson’s, and has been found in the cerebellum in AD (24).”
BackgroundInfluentialImaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 79
“During neuroinflammation, monoamine oxidase B (MAO B) is up-regulated in reactive astrocytes, and can be targeted in vivo using different PET tracers, such as [11C]-deuterium-Ldeprenyl-[11C]-DED- and [11C]-deprenyl-D2 [105].”
BackgroundCalaza, K. D. C., Martinez, A. B., Mendonça, H. R., & Carpi-Santos, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266910 · Cited by 64
“Neuroinflammation causes proliferation of glial cells, glial scar formation and neuronal and glial cell death (Cerami et al., 2017); therefore, the investigation of its modulation are timely and of great interest.”
BackgroundPiazza, F., Caminiti, S. P., Zedde, M., Presotto, L., DiFrancesco, J. C., Pascarella, R., Giossi, A., Sessa, M., Poli, L., Basso, G., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200892 · Cited by 69
Self-citationBerdyyeva, T., Xia, C., Taylor, N., He, Y., Chen, G., Huang, C., Zhang, W., Kolb, H., Letavic, M., Bhattacharya, A., et al. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-018-01313-2 · Cited by 60
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
Terada, T., Yokokura, M., Obi, T., Bunai, T., Yoshikawa, E., Ando, I., Shimada, H., Suhara, T., Higuchi, M., & Ouchi, Y. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09400-2 · Cited by 60
Fibromyalgia and Risk of Dementia—A Nationwide, Population-Based, Cohort Study
Tzeng, N., Chung, C., Liu, F., Chiu, Y., Chang, H., Yeh, C., Huang, S., Lu, R., Yeh, H., Kao, Y., et al. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.09.002 · Cited by 62
“Previous studies have shown that systemic or brain inflammation might contribute to neurodegeneration in dementia and worsening cognitive declines in patients with Alzheimer-type dementia.(50,51) Furthermore, 1 study found that fibromyalgia patients had significantly smaller hippocampi in both the left and right hemis…”
ResultTSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Weehaeghe, D. V., Schoor, E. V., Vocht, J. D., Koole, M. J. B., Attili, B. N. N. R., Celen, S., Declercq, L., Thal, D. R., Damme, P. V., Bormans, G. M., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.231985 · Cited by 60
“However, TSPO imaging has some drawbacks: relatively low signal-to-noise ratio, endothelial binding (7), and the need for genotyping before scanning (8).”
Background11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“Currently, (11)CPK11195 remains the prototypical and most validated tracer to investigate microglia activation in vivo, its cortical binding is not influenced by genotype, and it has been applied in several neurodegenerative condition, showing reproducible results.(66) The involvement of both motor and extra-motor cor…”
BackgroundSelf-citationMendonça, H. R., Carvalho, J. N. A., Abreu, C. A., dos Santos, D. M. D. S. A., Carvalho, J. R., Marques, S. A., Calaza, K. D. C., & Martinez, A. M. B. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.018 · Cited by 49
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45
Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
Chitre, N. M., Moniri, N. H., & Murnane, K. S. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666191114093749 · Cited by 234
Regulation of Mitochondrial, Cellular, and Organismal Functions by TSPO
Gavish, M., & Veenman, L. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.09.004 · Cited by 51
Bennett, J. P., Keeney, P. M., & Brohawn, D. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00235 · Cited by 39
Schwarz, A. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01027-4 · Cited by 42
Cognitive dysfunction in SLE: An understudied clinical manifestation
Mizrachi, M., Anderson, E., Carroll, K. R., Tehrani, N., Volpe, B. T., & Diamond, B. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102911 · Cited by 43
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
van Wetering, J., Geut, H., Bol, J. G. J. M., Galis, Y., Timmermans, E., Twisk, J. W. R., Hepp, D. H., Morella, M. L., Pihlstrøm, L., Lemstra, A. W., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01786-z · Cited by 48
“Likewise, 11 C-PK11195 binding was increased in early AD, suggesting that microglial activation is an early event in both DLB and AD [49, 50].”
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
A potential impact of Helicobacter pylori -related galectin-3 in neurodegeneration
Boziki, M. K., Pοlyzos, S. A., Deretzi, G., Kazakos, E. I., Katsinelos, P., Doulberis, M., Kotronis, G., Giartza‐Taxidou, E., Laskaridis, L., Tzivras, D., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.003 · Cited by 32
“a cascade of aberrant biochemical, metabolic, functional and structural changes (Cerami et al., 2017).”
Tobeh, N. S., & Bruce, K. D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1259012 · Cited by 38
Tondo, G., Boccalini, C., Caminiti, S. P., Presotto, L., Filippi, M., Magnani, G., Frisoni, G. B., Iannaccone, S., & Perani, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201351 · Cited by 29
“Variable results across studies emerged, mainly due to different quantification methods of the TSPO signal [43, 44].”
Self-citationWallin, J., & Svenningsson, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115606 · Cited by 31
“Evidence for elevated activation of microglia in vivo has been found through positron emission tomography (PET) where different tracers targeting translocator protein (TSPO), a mitochondrial membrane protein on activated microglia, shows increased binding in PD patients over healthy controls [16,17].”
BackgroundMolecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update
Govindula, A., Pai, A., Baghel, S. S., & Mudgal, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174364 · Cited by 35
Duran-Aniotz, C., Orellana, P., Leon Rodriguez, T., Henriquez, F., Cabello, V., Aguirre-Pinto, M. F., Escobedo, T., Takada, L. T., Pina-Escudero, S. D., Lopez, O., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.663407 · Cited by 26
Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
Nguyen, A. T., & Kim, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071840 · Cited by 28
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 27
“(R)-[(11)C]PK11195 was the first and prototypical TSPO tracer [193] and has been largely adopted in neurodegenerative conditions [179,191,194,195].”
BackgroundSelf-citationLisova, K., Wang, J., Hajagos, T. J., Lu, Y., Hsiao, A. P., Elizarov, A. M., & van Dam, R. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99111-4 · Cited by 22
Wood, P. L., Cebak, J. E., & Woltjer, R. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.009 · Cited by 20
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 21
Self-citationCerebrovascular disease: Neuroimaging of cerebral small vessel disease
Shaaban, C. E., Jorgensen, D. R., Gianaros, P. J., Mettenburg, J., & Rosano, C. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.008 · Cited by 21
Trotta, M. C., Gharbia, S., Herman, H., Mladin, B., Hermenean, A. G., Baltă, C., Cotoraci, C. A., Peteu, V. E., Gesualdo, C., Petrillo, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126280 · Cited by 24
“…[2]. the damage in male mice than in female Retinal neurodegenerative diseases are associated with neuroinflammation, chronic activation and proliferation of the microglia, alongside with neuronal and glial cell death [3], that leads to morphological alterations and visual impairment [4]. mice [8].”
Lee, H. J., Lee, E.-C., Seo, S., Ko, K., Kang, J. M., Kim, W., Seo, H., Lee, S.-Y., Lee, Y., Park, K. H., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615467 · Cited by 19
“Role of neuroinflammation has emerged in the development of neurodegenerative disorders (Cerami et al., 2017).”
BackgroundRole of Total Body PET/CT in Inflammatory Disorders
Zoghi, S., Mingels, C., Badawi, R. D., Spencer, B. A., Yarbrough, T. L., Nardo, L., & Chaudhari, A. J. (2024) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2024.11.001 · Cited by 22
“120 Furthermore, there are clinical trials currently underway, led by Taswell et al., to assess whether LAFOV scanners can be utilized to improve the evaluation and monitoring of both peripheral and central demyelination in MS. 121 In this setting, LAFOV scanners particularly beneficial due to…”
Weidner, L., Lorenz, J., Quach, S., Braun, F., Rothhammer-Hampl, T., Ammer, L.-M., Vollmann‐Zwerenz, A., Bartos, L. M., Dekorsy, F. J., Holzgreve, A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01651-5 · Cited by 23
“However, this study used the [ 18 F]DPA-714 imaging tracer and a different spectrum of tumors (smaller total number: 9 vs. 26 patients in our study, focus on IDH-mutant gliomas, only one GBM vs. 26 in our study) so that the results may not be entirely comparable.”
InfluentialNew PET markers for the diagnosis of dementia
Payoux, P., & Salabert, A. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000489 · Cited by 15
Synthesis and in vitro evaluation of fluorine-18 benzimidazole sulfones as CB2 PET-radioligands
Kallinen, A., Boyd, R. A., Lane, S., Bhalla, R., Mardon, K., Stimson, D. H. R., Werry, E. L., Fulton, R., Connor, M. A., & Kassiou, M. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00656g · Cited by 13
Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis
Ye, B., He, D., Hu, J., Yang, S., Gao, X., Cui, M., Li, Z., Wang, H., Huang, B., Fu, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110334 · Cited by 13
Sesquiterpenes from the Endophyte Glomerella cingulata
Liu, Y., Li, Y., Liu, Z., Li, L., Qu, J., Ma, S., Chen, R., Dai, J., & Yu, S. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00054 · Cited by 14
Imaging Biomarkers for Monitoring the Inflammatory Redox Landscape in the Brain
Fernandes, E. F. A., & Özcelik, D. (2021) · Antioxidants · doi:10.3390/antiox10040528 · Cited by 14
“TSPO imaging has been used to track disease severity and the efficacy of treatments in neurodegenerative disorders, such as Alzheimer’s disease and dementia [167,168].”
MethodFan, Q., Wu, Y.-Z., Jia, X.-X., Ruhan, A., Liu, C.-M., Zhang, W., Chao, Z.-Y., Zhou, D. H., Wang, Y., Chen, J., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00344 · Cited by 12
Nguyen, A. T., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310552 · Cited by 11
Chronic Postsurgical Pain Raises Risk of Dementia
Sun, M., Wang, X., Lu, Z., Yang, Y., Lv, S., Miao, M., Chen, W., Wu, S., & Zhang, J. (2025) · European Journal of Pain · doi:10.1002/ejp.70002 · Cited by 9
“…cytokines such as interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), which contribute to synaptic dysfunction, neuronal injury, and cognitive impairment (Bruunsgaard et al. 1999; Cerami et al. 2017; Lopez-Valdes and Martinez-Coria 2016; Pasqualetti et al. 2015; Yang et al. 2022).”
Neuroinflammation as an Integral Component of Neurodegeneration in Parkinson's Disease
Sayfitdinkhuzhaev, Z. F., Zhukova, N., & Baidanova, A. N. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-4-26-33 · Cited by 6
Russo, M. A., Tomino, C., Vernucci, E., Limana, F., Sansone, L., Frustaci, A., & Tafani, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7935310 · Cited by 9
“Misfolded proteins Misfolding of β-sheet-rich proteins, such as amyloid β-protein tau, tau, α-synuclein, and prion protein (PrP) [1, 24]”
BackgroundWang, X., Xu, W., Miao, C., Dong, F., Li, W., Wang, M., Gao, M., Zheng, Q., & Xu, Z. (2017) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2017.11.005 · Cited by 5
Evaluation of advanced, pathophysiologic new targets for imaging of CNS
Singh, P., Singh, D., Srivastava, P., Mishra, G., & Tiwari, A. K. (2023) · Drug Development Research · doi:10.1002/ddr.22040 · Cited by 5
TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders
Werry, E. L., Bright, F., & Kassiou, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_17 · Cited by 6
Jia, L., Miao, C., Dong, F., Li, W., Wang, M., Zheng, Q., & Xu, Z. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.036 · Cited by 4
Harm! foul! How acute kidney injury SHReDDs patient futures
Hebert, J. F., Funahashi, Y., & Hutchens, M. P. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000864 · Cited by 5
“Significant advances in assessment of intracranial inflammation such as novel-contrast MRI, molecular imaging, and cerebrospinal fluid biomarkers may provide avenues for translational study [12,13].”
BackgroundSynthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands
Kallinen, A., Mardon, K., Lane, S., Montgomery, A. P., Bhalla, R., Stimson, D. H. R., Ahamed, M., Cowin, G., Hibbs, D. E., Werry, E. L., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00345 · Cited by 4
SPECT/PET Findings in Dementia with Lewy Bodies
Zabihi, S., Whitfield, T. J., & Walker, Z. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_17 · Cited by 3
Tang, C., & Militano, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-01523-7_3 · Cited by 2
Positron Emission Tomography of the Reward System
Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · Neuromethods · doi:10.1007/978-1-0716-1146-3_14 · Cited by 1
Pantaleão, L. D. N. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2017.tde-07122017-160130
Bezukladova, S. (2018) · Doria (University of Helsinki)
In Vivo Optical Imaging for Immune Response
Liu, S., Feng, W., Zhang, C., Yu, T., & Zhu, D. Y. (2019) · Wiley eBooks · doi:10.1002/9780470015902.a0027292
Imagem PET de processos relacionados à esclerose múltipla: estudo pré-clínico
Carvalho, R. H. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-17042019-082221
de Souza, A. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-20072021-164522
Bienko, N., Burhanullah, M. H., & Munro, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_961 · Cited by 1
Bienko, N., Burhanullah, M. H., & Munro, C. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_961-1 · Cited by 1
Immune dysregulation and neurodegenerative diseases
Cipollini, V., Troili, F., & Giubilei, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00015-8
Étude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
Future directions in neuropsychology and neurosciences
Bhaskar, R., Singh, K. K., & Han, S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36544-7.00001-x
Metadata
- Authors
- Cerami, C., Iaccarino, L., & Perani, D.
- Affiliations
- IRCCS Ospedale San Raffaele (IT)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Cerami, Chiara
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-05-05
- Volume
- 18
- Issue
- 5
- Pages
- 993
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5454906
- OpenAlex
- W2611177721
- Cited by
- 75
- References
- 106
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 3 · 2021: 11 · 2020: 10 · 2019: 22 · 2018: 6 · 2017: 8
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Eli Lilly and Company
- Ministero dell’Istruzione, dell’Università e della Ricerca
- FP7 Health (278850)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- neuroinflammation, neurodegenerative dementia, positron emission tomography, microglial activation, astrocyte activation, Alzheimer's disease, frontotemporal lobar degeneration, proteinopathies, PET radiotracer, immune cell recruitment
- MeSH terms
- Alzheimer Disease, Humans, Inflammation, Microglia, Receptors, GABA, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.